Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre study.
Journal Information
Full Title: Graefes Arch Clin Exp Ophthalmol
Abbreviation: Graefes Arch Clin Exp Ophthalmol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approvalThis study concurs with the 1964 Helsinki declaration and its later amendments, and was approved by our institutional ethics committee of the university of Goettingen (application number is 6/11/20). Conflict of interestNina-Antonia Grimm: Speaker: Novartis AG, Bayer AG, OD-OS GmbH.Sarah Fahimi: No conflict of interest.Fabian Kück: No conflict of interest.Patricia Take: No conflict of interest.Peer Lauermann: No conflict of interest.Anna Nguyen-Hoehl: No conflict of interest.Hans Hoerauf: Consultant: Novartis, Roche Allergan; Speaker: Novartis, Roche, Allergan, Biogen, Alcon, Heidelberg Engeneering; Research projects: Bayer Heath Care, Novartis, Allergan, chengdu Khanghong, Biotec, Hoffmann LaRoche, Samsung, Benevolent, Regeneron, Santen GmbH, Boehringer Ingelheim, Mylan, Appelis; Owner interest in medical products: Novartis, Bayer, 3 M, Roche, Johnson&Johnson, Mediatronis, Abbvie, Pfizer.Nicolas Feltgen: Consultant: Alimera Sciences, Novartis, Roche; Speaker: Allergan, Alimera, Bayer, Heidelberg Engineering, Novartis, Roche.Sebastian Bemme: Speaker: Novartis AG, Bayer AG; Research grant: Novartis AG. Conflict of interest Nina-Antonia Grimm: Speaker: Novartis AG, Bayer AG, OD-OS GmbH. Sarah Fahimi: No conflict of interest. Fabian Kück: No conflict of interest. Patricia Take: No conflict of interest. Peer Lauermann: No conflict of interest. Anna Nguyen-Hoehl: No conflict of interest. Hans Hoerauf: Consultant: Novartis, Roche Allergan; Speaker: Novartis, Roche, Allergan, Biogen, Alcon, Heidelberg Engeneering; Research projects: Bayer Heath Care, Novartis, Allergan, chengdu Khanghong, Biotec, Hoffmann LaRoche, Samsung, Benevolent, Regeneron, Santen GmbH, Boehringer Ingelheim, Mylan, Appelis; Owner interest in medical products: Novartis, Bayer, 3 M, Roche, Johnson&Johnson, Mediatronis, Abbvie, Pfizer. Nicolas Feltgen: Consultant: Alimera Sciences, Novartis, Roche; Speaker: Allergan, Alimera, Bayer, Heidelberg Engineering, Novartis, Roche. Sebastian Bemme: Speaker: Novartis AG, Bayer AG; Research grant: Novartis AG."
"Funding Open Access funding enabled and organized by Projekt DEAL."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025